Current Topics in Medicinal Chemistry

Editorial [ The Use of Selective Fluorination in Drug Design and Development Guest Editor: Dr. Kenneth L. Kirk ]
pp. 1445-1445(1)
Author: Kirk, Kenneth L.

Selective Fluorination in Drug Design and Development: An Overview of Biochemical Rationales
pp. 1447-1456(10)
Author: Kirk, Kenneth L.

Fluorinated Molecules as Drugs and Imaging Agents in the CNS
pp. 1457-1464(8)
Authors: Sun, Shengguo; Adejare, Adeboye

Design and Synthesis of Phosphonodifluoromethyl Phenylalanine (F2Pmp):A Useful Phosphotyrosyl Mimetic
pp. 1465-1471(7)
Author: Burke, Terrence R.

The Strength of Weak Interactions: Aromatic Fluorine in Drug Design
pp. 1473-1482(10)
Authors: DiMagno, Stephen G.; Sun, Haoran

How Cα-Fluoroalkyl Amino Acids and Peptides Interact with Enzymes:Studies Concerning the Influence on Proteolytic Stability, Enzymatic Resolution and Peptide Coupling
pp. 1483-1498(16)
Authors: Smits, Rene; Koksch, Beate

Fluorinated Nucleosides as Antiviral and Antitumor Agents
pp. 1499-1528(30)
Authors: Meng, Wei-Dong; Qing, Feng-Ling

Fluorinated Natural Products with Clinical Significance
pp. 1529-1543(15)
Author: Thomas, Craig J.

Peptidyl Fluoro-Ketones as Proteolytic Enzyme Inhibitors
pp. 1545-1566(22)
Authors: Sani, Monica; Sinisi, Roberta; Viani, Fiorenza